Hydrothermal degradation deteriorates the fracture toughness and strength of tetragonal stabilised zirconia. The phase transformation to the monoclinic phase is particularly critical for materials with lower stabiliser content such as 2 mol% and 3 mol% yttria stabilised zirconia (2YSZ and 3YSZ). In this work, two routes in two-step sintering and co-doping with calcium oxide are analysed to mitigate the degradation. Both strategies show a reduction in average grain size of the 2YSZ while maintaining a comparable densification. The achieved smaller grains suppress the hydrothermal degradation rates. In addition, a mitigating effect beyond the reduction in grain size of YSZ is found for CaO doping. 1.6 mol% CaO co-doped 2YSZ shows less than 4% of monoclinic phase after 50 h in an autoclave with H2O at 134 °C. Pure 2YSZ contrarily reaches 100% monoclinic phase after 20 h at the same conditions. A suppression of degradation by CaO doping was also observed for the composite of nickel oxide and 3 mol% yttria stabilised zirconia. Hence, CaO co-doping can be an interesting strategy to increase resistivity against hydrothermal degradation for both biomedical and renewable energy applications. The findings further outline a route to achieve tetragonal YSZ with lower yttria contents than 2 mol%.
Read full abstract